Research progress on anti-carbamylated protein antibodies in connective tissue disease
Connective tissue disease （CTD） is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies. As a newly discovered autoantibody in recent years， anti-ca...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of New Medicine
2023-04-01
|
| Series: | Xin yixue |
| Subjects: | |
| Online Access: | https://www.xinyixue.cn/fileup/0253-9802/PDF/1683603140121-1685840816.pdf |
| Summary: | Connective tissue disease （CTD） is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies. As a newly discovered autoantibody in recent years， anti-carbamylated protein （anti-CarP） antibodies play an important role in the diagnosis， stratification and treatment evaluation of various CTDs. This article reviews the research progress on anti-CarP antibodies in CTD. |
|---|---|
| ISSN: | 0253-9802 |